Directly informed by the results of ATN 113: PrEPare, emtricitabine/tenofovir (brand name Truvada) was approved for adolescents as pre-exposure prophylaxis (PrEP) for HIV prevention.

Why It Matters

The addition of oral PrEP to the HIV prevention toolbox for adolescents provided access to an effective biomedical prevention medication for the first time.